$PFE News Stock market live blog: SP 500 record, Twitter

New Post Public Reply Private Reply Replies (0) Message Board

Nov 21, 2013 at 6:22 PM

$PFE News

Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
How to buy bitcoin 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com

Pfizer Gets FDA Nod for Xalkori Lung Cancer Drug and 2 Other Dow Movers to Watch 1:53 p.m. Today - Wall St. Cheat Sheet
Data on Amgen's Pipeline Candidates - Analyst Blog 11:50 a.m. Today - Zacks.com
Stock Market News for November 21, 2013 - Market News 10:06 a.m. Today - Zacks.com
Athersys Narrows Loss, Shares Rise - Analyst Blog 9:00 a.m. Today - Zacks.com
Daiichi Sankyo's Factor Xa Inhibitor Edoxaban Clears Phase III Hurdle - A Major Threat To Xarelto And Eliquis 8:35 a.m. Today - Seeking Alpha
Roche's Kadcyla Approved in the EU - Analyst Blog 5:35 p.m. Nov. 20, 2013 - Zacks.com
Will Recent News Hurt Johnson & Johnson? 5:08 p.m. Nov. 20, 2013 - Wall St. Cheat Sheet
Amazon.com Cloud Push Seen Creating 'Losers' In IT 4:21 p.m. Nov. 20, 2013 - Investors Business Daily
Early Warning Signs of a Dividend Cut 10:39 a.m. Nov. 20, 2013 - GuruFocus.com
Daiichi Sankyo's edoxaban holds its own in clinical testing 10:26 a.m. Nov. 20, 2013 - Seeking Alpha
EU Clears Roche Cancer Drug 5:44 a.m. Nov. 20, 2013 - WSJ.com
More Boards Recruit Ex-CEOs 9:47 p.m. Nov. 19, 2013 - WSJ.com
QIAGEN, Eli Lilly Expand Partnership - Analyst Blog 6:58 p.m. Nov. 19, 2013 - Zacks.com
New Tricks in Animal Health 6:05 p.m. Nov. 19, 2013 - WSJ.com
Nokia Shareholders Nod to Microsoft Deal and 2 Other Hot Stocks to Watch 12:38 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Bullying: Deal With It 12:16 p.m. Nov. 19, 2013 - FOXBusiness
The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years 11:03 a.m. Nov. 19, 2013 - 247WallSt.com
Salesforce's Q3 Loss Widens - Analyst Blog 9:30 a.m. Nov. 19, 2013 - Zacks.com
Pfizer Inc's Buy Recommendation Affirmed 9:00 a.m. Nov. 19, 2013 - TheStreet.com
4 ETFs to Turbocharge Your Returns 3:22 a.m. Nov. 19, 2013 - InvestorPlace.com

Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Today - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Today - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Today - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Today - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Eluvio's Game-Changer: AI Integrated Direct to Stream

A groundbreaking change is thrust upon the video streaming landscape, disrupting traditional workflows. Eluvio, with its Universal & Dynamic Video Intelligence Architecture, is not just tweaking the formula; it's setting a brand-new standard. Their innovations were on full display at the IBC Show 2026 in Amsterdam, and believe me, they're redefining how we think about...

Geron Faces Legal Woes: Investors Watch for Fallout

Legal Storm Brewing Around Geron Corporation Ah, the familiar smell of trouble in corporate paradise, and this time it's drifting from Geron Corporation (NASDAQ: GERN). If you've got your chips on the table with these guys, you'd better pony up and listen up. Kuehn Law, PLLC is lighting a fire under Geron's board, snooping on whether their head honchos scuttled their...

Spencer Spirit Completes Hot Topic Acquisition

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Intrigue Over Guadalupe River Property Bid

Straight up, a chance like this doesn't float by every day. The Guadalupe River portfolio, with its mix of entertainment, hospitality, and commercial assets up for grabs in New Braunfels, Texas, is the talk of the investor town. If you've got deep pockets and a keen eye for opportunities, you're gonna want a piece of this pie before the September 22 bid deadline hits. The...

Max Stock Expands with Strategic Logistics Center

Expansion in Full Swing In a move that might get tongues wagging in the boardrooms across Israel, Max Stock Limited (TASE: MAXO) just signed a hefty lease for a logistics center in Ofakim. This isn't just a modest expansion—it's a jaw-dropper at about 45,000 square meters. We're talking about a major upgrade that'll beef up their logistical backbone as they continue...

Wahl's Bold Move: The Baldscaper™ Revolution

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Ares Management Heads to Barclays Conference Spotlight

All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...

Insilico Joins HKEX Tech 100: AI and Pharma Synergies

Insilico Medicine just locked down a spot in the HKEX Tech 100 Index, and that's a pretty big deal, if you ask me. This Cambridge-based outfit is making waves with its generative AI wizardry in drug discovery. It's not just about earning a tech badge of honor here; it's about opening doors to new investors and bolstering liquidity. When changes hit on September 14, 2026,...

York Space Systems Faces Class Action After IPO Issues

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Tahoe Truckee Life TV Series Elevates Local Flavor

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...